Join us for our next Insights Forum:

Save the date for our next Insights Forum:
Thursday, May 18, 2023
10 - 11:30 a.m. Pacific
10 - 11:30 a.m. Pacific
Forum Topic: Artificial Intelligence in Cancer
The ACS recently reported that 1,958,310 Americans will receive a cancer
diagnosis, and 609,820 will die from their disease this year. These are daunting statistics, but the ACS report also emphasized that the death rate from cancer has declined by roughly 33% since 1991, amounting to 3.8 million “deaths averted.”
Unfortunately, this decline in the death rate is not evenly distributed across all cancers, nor has much changed with cancers such as pancreas and glioblastoma (GBM), and even more common cancers such as prostate and breast once they have metastasized.
Join us for our Insights Forum on Feb. 23 as our panel of experts take a hard look at why progress has been uneven and how new thinking and ideas could be transformative!
Unfortunately, this decline in the death rate is not evenly distributed across all cancers, nor has much changed with cancers such as pancreas and glioblastoma (GBM), and even more common cancers such as prostate and breast once they have metastasized.
Join us for our Insights Forum on Feb. 23 as our panel of experts take a hard look at why progress has been uneven and how new thinking and ideas could be transformative!
Panelists:
• Christopher Logothetis, MD | MD Anderson Cancer Center
• Paul Mischel, MD | Stanford University
• George Sledge, Jr., MD | Caris Life Sciences
• David Tuveson, MD, PhD, FAACR | Cold Spring Harbor Laboratory
Moderated by:
• David Agus, MD | Ellison Institute
• Anna Barker, PhD, FAACR | Ellison Institute
• Christopher Logothetis, MD | MD Anderson Cancer Center
• Paul Mischel, MD | Stanford University
• George Sledge, Jr., MD | Caris Life Sciences
• David Tuveson, MD, PhD, FAACR | Cold Spring Harbor Laboratory
Moderated by:
• David Agus, MD | Ellison Institute
• Anna Barker, PhD, FAACR | Ellison Institute
REGISTER NOW
Past Insights Forum Recordings
IMMUNOTHERAPHY
December 2022
______
If cancer immunotherapy is the answer to improving treatment or even curing or preventing most cancers, what are the research imperatives at this point? Are we doing enough to address these imperatives? If not, why not, and how can that be remedied?
December 2022
______
If cancer immunotherapy is the answer to improving treatment or even curing or preventing most cancers, what are the research imperatives at this point? Are we doing enough to address these imperatives? If not, why not, and how can that be remedied?
WHAT ARE WE MISSING IN OUR 50-YEAR QUEST TO FUNDAMENTALLY UNDERSTAND & CONTROL CANCER?
September 2022
______
Cancer is complex. It is a complex adaptive system, but is it irreducibly complex? If not, what are we missing that could enable progress? Our panel of experts explored this question and provided their insights.
September 2022
______
Cancer is complex. It is a complex adaptive system, but is it irreducibly complex? If not, what are we missing that could enable progress? Our panel of experts explored this question and provided their insights.
PRECISION ONCOLOGY: SEPARATING HOPE FROM HYPE
May 2022
______
Where, how, and why is precision oncology working predictably and well?
Where and why is precision oncology not working well - or at all?
What is needed for all cancer patients to have access to efficacious precision
oncology in the future?
May 2022
______
Where, how, and why is precision oncology working predictably and well?
Where and why is precision oncology not working well - or at all?
What is needed for all cancer patients to have access to efficacious precision
oncology in the future?
EARLY CANCER DETECTION & PREVENTION:
THE NEW FRONTIER
February 2022
______
Are we on the cusp of a revolution in cancer? Is early detection of cancer the new frontier in cancer progression--or not? If so, what will be required (e.g., intervention strategies/technologies) to achieve needed changes in all sectors? If not, could very early detection of pre-cancer "signals" create unprecedented challenges?
THE NEW FRONTIER
February 2022
______
Are we on the cusp of a revolution in cancer? Is early detection of cancer the new frontier in cancer progression--or not? If so, what will be required (e.g., intervention strategies/technologies) to achieve needed changes in all sectors? If not, could very early detection of pre-cancer "signals" create unprecedented challenges?
INFORMATION THEORY
October 2021
______
If cancer is a dynamic information-driven complex adaptive system, what steps must be taken to shift from studying its “parts” vs. decoding and decrypting the information we need to identify and understand the flow of information and the logic of the system?
October 2021
______
If cancer is a dynamic information-driven complex adaptive system, what steps must be taken to shift from studying its “parts” vs. decoding and decrypting the information we need to identify and understand the flow of information and the logic of the system?
THE PHYSICS OF CANCER
July 2021
______
In the context of the convergence of the physical sciences with cancer biology, is research in the physical sciences clinically relevant? What will it take to advance promising areas of the physical sciences to solve critical questions in cancer that could lead to clinical breakthroughs?
July 2021
______
In the context of the convergence of the physical sciences with cancer biology, is research in the physical sciences clinically relevant? What will it take to advance promising areas of the physical sciences to solve critical questions in cancer that could lead to clinical breakthroughs?
DECONVOLUTING CANCER COMPLEXITY
May 2021
______
We are awash in data from cancer patients, but if data are not information, what and where is dysregulated cancer information, how do we collect it and is it critical for the diagnosis and treatment of cancer?
May 2021
______
We are awash in data from cancer patients, but if data are not information, what and where is dysregulated cancer information, how do we collect it and is it critical for the diagnosis and treatment of cancer?
REVOLUTIONIZING CANCER TREATMENT THROUGH EVOLUTIONARY THEORY
March 2021
______
How could applying specific principles of evolution / evolutionary theory (and ecology) across biological and temporal scales of cancer revolutionize treatment strategies, reduce resistance, and improve patient outcomes?
March 2021
______
How could applying specific principles of evolution / evolutionary theory (and ecology) across biological and temporal scales of cancer revolutionize treatment strategies, reduce resistance, and improve patient outcomes?
PRECISION MEDICINE FOR COVID-19
January 2021
______
Can we use the precision cancer medicine model to inform and improve the diagnosis and prevention of COVID-19 infections and treatment of the disease(s) it causes?
January 2021
______
Can we use the precision cancer medicine model to inform and improve the diagnosis and prevention of COVID-19 infections and treatment of the disease(s) it causes?
IMMUNOTHERAPY
December 2022
______
If cancer immunotherapy is the answer to improving treatment or even curing or preventing most cancers, what are the research imperatives at this point? Are we doing enough to address these imperatives? If not, why not, and how can that be remedied?
December 2022
______
If cancer immunotherapy is the answer to improving treatment or even curing or preventing most cancers, what are the research imperatives at this point? Are we doing enough to address these imperatives? If not, why not, and how can that be remedied?
WHAT ARE WE MISSING IN OUR 50-YEAR QUEST TO FUNDAMENTALLY UNDERSTAND & CONTROL CANCER?
September 2022
______
Cancer is complex. It is a complex adaptive system, but is it irreducibly complex? If not, what are we missing that could enable progress? Our panel of experts explored this question and provided their insights.
September 2022
______
Cancer is complex. It is a complex adaptive system, but is it irreducibly complex? If not, what are we missing that could enable progress? Our panel of experts explored this question and provided their insights.
PRECISION ONCOLOGY: SEPARATING HOPE FROM HYPE
May 2022
______
Where, how, and why is precision oncology working predictably and well? Where and why is precision oncology not working well - or at all? What is needed for all cancer patients to have access to efficacious precision oncology in the future?
May 2022
______
Where, how, and why is precision oncology working predictably and well? Where and why is precision oncology not working well - or at all? What is needed for all cancer patients to have access to efficacious precision oncology in the future?
EARLY CANCER DETECTION & PREVENTION: THE NEW FRONTIER
February 2022
______
Are we on the cusp of a revolution in cancer? Is early detection of cancer the new frontier in cancer progression--or not? If so, what will be required (e.g., intervention strategies/technologies) to achieve needed changes in all sectors? If not, could very early detection of pre-cancer "signals" create unprecedented challenges?
February 2022
______
Are we on the cusp of a revolution in cancer? Is early detection of cancer the new frontier in cancer progression--or not? If so, what will be required (e.g., intervention strategies/technologies) to achieve needed changes in all sectors? If not, could very early detection of pre-cancer "signals" create unprecedented challenges?
INFORMATION THEORY
October 2021
______
If cancer is a dynamic information-driven complex adaptive system, what steps must be taken to shift from studying its “parts” vs. decoding and decrypting the information we need to identify and understand the flow of information and the logic of the system?
October 2021
______
If cancer is a dynamic information-driven complex adaptive system, what steps must be taken to shift from studying its “parts” vs. decoding and decrypting the information we need to identify and understand the flow of information and the logic of the system?
THE PHYSICS OF CANCER
July 2021
______
In the context of the convergence of the physical sciences with cancer biology, is research in the physical sciences clinically relevant? What will it take to advance promising areas of the physical sciences to solve critical questions in cancer that could lead to clinical breakthroughs?
July 2021
______
In the context of the convergence of the physical sciences with cancer biology, is research in the physical sciences clinically relevant? What will it take to advance promising areas of the physical sciences to solve critical questions in cancer that could lead to clinical breakthroughs?
DECONVOLUTING CANCER COMPLEXITY
May 2021
______
We are awash in data from cancer patients, but if data are not information, what and where is dysregulated cancer information, how do we collect it and is it critical for the diagnosis and treatment of cancer?
May 2021
______
We are awash in data from cancer patients, but if data are not information, what and where is dysregulated cancer information, how do we collect it and is it critical for the diagnosis and treatment of cancer?
REVOLUTIONIZING CANCER TREATMENT THROUGH EVOLUTIONARY THEORY
March 2021
______
How could applying specific principles of evolution / evolutionary theory (and ecology) across biological and temporal scales of cancer revolutionize treatment strategies, reduce resistance, and improve patient outcomes?
March 2021
______
How could applying specific principles of evolution / evolutionary theory (and ecology) across biological and temporal scales of cancer revolutionize treatment strategies, reduce resistance, and improve patient outcomes?
PRECISION MEDICINE FOR COVID-19
January 2021
______
Can we use the precision cancer medicine model to inform and improve the diagnosis and prevention of COVID-19 infections and treatment of the disease(s) it causes?
January 2021
______
Can we use the precision cancer medicine model to inform and improve the diagnosis and prevention of COVID-19 infections and treatment of the disease(s) it causes?